8-K

Company

Xeris Biopharma Holdings, Inc.

Filed

November 10, 2021

Period of Report

November 10, 2021

Accession Number

0001867096-21-000066

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →